A detailed history of Bli Banque De Luxembourg Investments transactions in Moderna, Inc. stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 15,000 shares of MRNA stock, worth $494,850. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$494,850
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$36.85 - $63.93 $552,750 - $958,950
15,000 New
15,000 $591 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bli Banque De Luxembourg Investments Portfolio

Follow Bli Banque De Luxembourg Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bli Banque De Luxembourg Investments, based on Form 13F filings with the SEC.

News

Stay updated on Bli Banque De Luxembourg Investments with notifications on news.